CONFO
TECHNOLOGY
SUPERIOR PLATFORM FOR
STRUCTURE-BASED DRUG DESIGN
LEARN MORE
TRANSFORMATIVE
MEDICINES
OUR DRUG DISCOVERY ENGINE IS
DELIVERING AN EXPANDING PIPELINE OF
NOVEL GPCR MODULATORS
LEARN MORE
CONFO TEAM OUR TEAM IS COMPOSED OF
TALENTED BIOPHARMACEUTICAL PROFESSIONALS
AND EXPERT SCIENTISTS
LEARN MORE

CONFO THERAPEUTICS

Stabilize. Target. Discover. Transform.

Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible drug targets.

Confo has attracted an international team of accomplished scientists and business professionals to deploy its innovative drug discovery platform on high value GPCR targets. With these valuable resources in place, Confo’s mission is to build a pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying treatments.

“At Confo, our multi-faceted approach to building value starts from our outstanding technology, our stellar team and a growing proprietary pipeline of novel drug candidates. We further validate our approach through strategic partnerships with industry leaders and a strong consortium of global investors.”

CEDRIC VERVERKEN / CEO

INVESTORS

OUR LATEST NEWS

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close